Background: Hepatoblastoma (HB) is a rare embryonal liver tumor, with an increasing global incidence that underscores the need to understand its genetic etiology. Methods: Utilizing the ancestry-matched expression quantitative loci data, we performed a HB transcriptome-wide association study (TWAS) on 4, 539 Europeans, 1, 047 Latinos, and 378 African Americans (∼1: 10 case-control ratio). We conducted a meta-analysis of multiancestry transcriptome-wide analysis (METRO), followed by METRO-Egger sensitivity analysis and ancestry-specific gene set enrichment analyses. We further explored genes with additional evidence gathered from independent cohorts and databases. Results: Across the three ancestries, the discovered genes shared the same effect direction across ancestries. A meta-analysis of the three ancestries identified 28 genes significantly associated with HB risk, and 15 were nominally significant for at least two ancestries. Our post-TWAS analyses highlighted 8 genes among these 28, including OXER1 (meta-analysis P value = 7. 34 × 10^-6), FADS1 (P value = 4. 01 × 10^-6), and UGDH (P value = 5. 29 × 10^-8), which were expressed in fetal liver hepatoblast cells and were differentially expressed in tumor and normal tissues in an independent Japanese HB study (P values = 2. 61 × 10^-13, 3. 62 × 10^-3, and 1. 95 × 10^-9, respectively). Conclusions: We pinpointed eight potential genes associated with HB using data from an ongoing multiancestry genome-wide association study. Impact: We conducted the largest HB TWAS to date, prompting further exploration of genes.
Xie et al. (Fri,) studied this question.